Ateria Health is a U.K.-based health and wellness biotech focused on gut microbiome products and research. The company owns ERME™ intellectual property and has commercialised JUVIA™ Digestive Balance Formula for the treatment of irritable bowel syndrome (IBS). Ateria develops and distributes supplements and has research interests in Australia. As part of its commercial strategy, the company intends reciprocal distribution arrangements to expand JUVIA™ into Australian and North American markets. The business is positioned to collaborate on joint R&D and leverage partner distribution channels to reach B2C online platforms, pharmacies, and retail. No operating financial metrics were disclosed in the article.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2022